2 results
Approved WMORecruiting
To assess the safety and tolerability of PLN 74809 in participants with PSC and suspected liver fibrosis
Approved WMOCompleted
Primary Objective:* To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing (CPET) following 20 weeks of treatment with OM or placeboSecondary…